article Open AccessTop 1% cited

Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy

British Journal of Cancer · 2011 · Vol. 105(9) · pp. 1295–1301

Michael Keidar✉(George Washington University)Ryan M. Walk(Children's National)Alexey Shashurin(George Washington University)Priya Srinivasan(Children's National)Anthony D. Sandler(Children's National)Santanu Dasgupta(Virginia Commonwealth University)Rajani Ravi(Johns Hopkins University)Rafael Guerrero‐Preston(Johns Hopkins Medicine)Barry Trink(Johns Hopkins Medicine)

View via DOI Full-text PDF

Abstract

The development of cold plasma tumour ablation has the potential of shifting the current paradigm of cancer treatment and enabling the transformation of cancer treatment technologies by utilisation of another state of matter.

Plasma Applications and Diagnostics Plasma Diagnostics and Applications Surface Modification and SuperhydrophobicityIn vivoPlasmaAtmospheric-pressure plasmaCancerCancer cellReactive oxygen speciesOxidative stressIn vitroChemistryOxidative phosphorylation

MeSH terms

AnimalsUrinary Bladder NeoplasmsMelanoma, ExperimentalMice, Inbred C57BLMice, NudeNeoplasm TransplantationSkin TemperatureSignal TransductionGene Expression ProfilingCell Line, TumorMicePlasma Gases

Citations

747

FWCI

25.08

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Cold atmospheric plasma in cancer therapy